S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

Published 2018 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth
Authors
Keywords
BCL-2; inhibitor; BH3-mimetics; apoptosis; hematological malignancies
Journal
Oncotarget
Volume 9, Issue 28, Pages -
Publisher
Impact Journals, LLC
Online
2018-04-13
DOI
10.18632/oncotarget.24744

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.